Investors

Investors

Corporate Overview

Ophthotech is a biopharmaceutical company specializing in the development of novel therapeutics to treat ophthalmic diseases, with a focus on orphan and age-related retinal diseases.

Jul 20, 2018 at 4:33 PM EDT

Copyright Nasdaq. Minimum 15 minutes delayed.